An oral abstract presented at IAS 2025 reported non-inferiority at 96 weeks after switching to two different dual ART therapies compared to remaining on three-drug combinations in Côte d’Ivoire, Burkino Faso and Cameroon.
Results of the French ANRS-sponsored MODERATO study were presented by Fatoumata Fadiga from the Programme PAC-CI-PRISME, Abidjan, Côte d’Ivoire.
Read the full news story at HIV i-Base.
All HIV i-Base reports from IAS 2025 can be accessed here.
Source : HIV i-Base
Related HIV and Co-Infections News
-
Infectious Disease Advisor: Switch to INSTI+NRTI ART regimens highly effective in virologically suppressed HIV
-
Scroll.in: Fight for cheaper HIV drugs: The extraordinary stories of an Indian and a South African
-
Infectious Disease Advisor: Long-acting ART possible therapeutic option for HIV with prior HBV exposure
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.